Resources (2)

February 16, 2021

Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Intestinal inflammatory diseases are highly complex, which has thus far prevented development of an effective in vitro disease model. With access to a donor-derived cell biobank and the ability to recapitulate region-specific environments of the intestine, Altis Biosystems is working toward the development of an in vitro RepliGut® model to accurately recapitulate the complex intestinal inflammatory microenvironments.

December 23, 2020

How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?

How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?

November 30, 2020

Enhancing Human Gut Tissue Models through Gene Editing

Enhancing Human Gut Tissue Models through Gene Editing

November 10, 2020

Increasing the Efficiency of Drug Development With Preclinical Testing Using Human Intestinal Stem Cells

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

October 23, 2020

Characterization of a Novel Human Primary Intestinal Epithelial Monolayer Platform in Response to Cytokine Challenge (Poster)

The ability to grow and expend primary human epithelial cells in vitro has been a significant advancement in the field of gastrointestinal biology. The ALTIS RepliGut® Planar system uses a proprietary biomimetic scaffold on a porous membrane to form a human intestinal epithelial monolayer...